Cargando…

The Impact of Preclinical High Potent P2Y(12) Inhibitors on Decision Making at Discharge and Clinical Outcomes in Patients with Acute Coronary Syndrome

Background: Purinergic signaling receptor Y(12) (P2Y(12)) inhibitors are a fundamental part of pharmacological therapy in acute coronary syndrome (ACS) for preventing recurrent ischemic events. Current guidelines support the use of prasugrel over ticagrelor—however, ticagrelor is widely used for pre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hammer, Andreas, Krammel, Mario, Aigner, Patrick, Pfenneberger, Georg, Schnaubelt, Sebastian, Hofer, Felix, Kazem, Niema, Koller, Lorenz, Steinacher, Eva, Baumer, Ulrike, Hengstenberg, Christian, Niessner, Alexander, Sulzgruber, Patrick
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10299011/ https://www.ncbi.nlm.nih.gov/pubmed/37373788 http://dx.doi.org/10.3390/jcm12124094

Ejemplares similares

An increase in acute heart failure offsets the reduction in acute coronary syndrome during coronavirus disease 2019 (COVID‐19) outbreak
por: Sulzgruber, Patrick, et al.
Publicado: (2020)

Cardiogenic Shock Does Not Portend Poor Long-Term Survival in Patients Undergoing Primary Percutaneous Coronary Intervention
por: Steinacher, Eva, et al.
Publicado: (2022)

The age-specific prognostic impact of the platelet-to-lymphocyte ratio on long-term outcome after acute coronary syndrome
por: Kazem, Niema, et al.
Publicado: (2021)

Expert Opinion: Meditation and Cardiovascular Health: What is the Link?
por: Schnaubelt, Sebastian, et al.
Publicado: (2019)

Relationship of Fibroblast Growth Factor 23 With Hospitalization for Heart Failure and Cardiovascular Outcomes in Patients Undergoing Cardiac Surgery
por: Hofer, Felix, et al.
Publicado: (2023)

The prognostic impact of left ventricular thrombus resolution after acute coronary syndrome and risk modulation via antithrombotic treatment strategies
por: Hofer, Felix, et al.
Publicado: (2021)

The impact of volume substitution on post‐operative atrial fibrillation
por: Schnaubelt, Sebastian, et al.
Publicado: (2020)

The Prognostic Impact of Circulating Regulatory T Lymphocytes on Mortality in Patients with Ischemic Heart Failure with Reduced Ejection Fraction
por: Hammer, Andreas, et al.
Publicado: (2020)

An Extended Duration of the Pre-Operative Hospitalization is Associated with an Increased Risk of Healthcare-Associated Infections after Cardiac Surgery
por: Sulzgruber, Patrick, et al.
Publicado: (2020)

Ethical considerations during critical care from an age-specific perspective
por: Sulzgruber, Patrick, et al.
Publicado: (2021)

Critical care during a pandemic —Are we prepared for the ethical dilemma?
por: Schnaubelt, Sebastian, et al.
Publicado: (2022)

Relationship of diabetes, heart failure, and N‐terminal pro‐B‐type natriuretic peptide with cardiovascular outcomes in patients with atrial fibrillation
por: Hofer, Felix, et al.
Publicado: (2022)

The personalized antithrombotic management of atrial fibrillation with intermediate thromboembolic risk: a case report
por: Hammer, Andreas, et al.
Publicado: (2020)

De-Ritis Ratio Improves Long-Term Risk Prediction after Acute Myocardial Infarction
por: Steininger, Matthias, et al.
Publicado: (2018)

BLS courses for refugees are feasible and induce commitment towards lay rescuer resuscitation
por: Schnaubelt, Sebastian, et al.
Publicado: (2021)

Immunomodulatory treatment for lymphocytic myocarditis—a systematic review and meta-analysis
por: Winter, Max-Paul, et al.
Publicado: (2018)

Out of sight – Out of mind? The need for a professional and standardized peri-mission first responder support model
por: Schnaubelt, Sebastian, et al.
Publicado: (2023)

The impact of CD4(+)CD28(null) T lymphocytes on atrial fibrillation: a potential pathophysiological pathway
por: Hammer, Andreas, et al.
Publicado: (2021)

Vericiguat: a fifth cornerstone in the treatment of heart failure with reduced ejection fraction?
por: Hammer, Andreas, et al.
Publicado: (2023)

The Epidemiology of Pre-Hospital EMS Treatment of Geriatric Patients in the City of Vienna—An Overview
por: Krammel, Mario, et al.
Publicado: (2023)

CD4(+)CD28(null) T Lymphocytes are Associated with the Development of Atrial Fibrillation after Elective Cardiac Surgery
por: Sulzgruber, Patrick, et al.
Publicado: (2018)

Differences in Automated External Defibrillator Types in Out-of-Hospital Cardiac Arrest Treated by Police First Responders
por: Krammel, Mario, et al.
Publicado: (2023)

Gender and age-specific aspects of awareness and knowledge in basic life support
por: Krammel, Mario, et al.
Publicado: (2018)

Butyrylcholinesterase Predicts Cardiac Mortality in Young Patients with Acute Coronary Syndrome
por: Sulzgruber, Patrick, et al.
Publicado: (2015)

PULS – Austrian Cardiac Arrest Awareness Association: An overview of a multi-tiered and multi-facetted regional initiative to save lives
por: Schnaubelt, Sebastian, et al.
Publicado: (2023)

Impaired High‐Density Lipoprotein Anti‐Oxidative Function Is Associated With Outcome in Patients With Chronic Heart Failure
por: Schrutka, Lore, et al.
Publicado: (2016)

The impact of a high-quality basic life support police-based first responder system on outcome after out-of-hospital cardiac arrest
por: Krammel, Mario, et al.
Publicado: (2020)

The Feasibility of Ultra-Sensitive Phonocardiography in Acute Chest Pain Patients of a Tertiary Care Emergency Department (ScorED Feasibility Study)
por: Schnaubelt, Sebastian, et al.
Publicado: (2022)

Hemodynamic effects of Vernakalant in cardio-surgical ICU-patients treated for recent-onset postoperative atrial fibrillation
por: Schnaubelt, S., et al.
Publicado: (2020)

Body Weight Counts—Cardioversion with Vernakalant or Ibutilide at the Emergency Department
por: Lindmayr, Teresa, et al.
Publicado: (2022)

Propensity for Calcification in Serum Associates With 2-Year Cardiovascular Mortality in Ischemic Heart Failure With Reduced Ejection Fraction
por: Bojic, Marija, et al.
Publicado: (2021)

Cardiac biomarkers predict mortality in emergency patients presenting with atrial fibrillation
por: Niederdöckl, Jan, et al.
Publicado: (2019)

Prehospital emergency medicine research by additional teams on scene – Concepts and lessons learned
por: Mueller, Matthias, et al.
Publicado: (2023)

Translational Animal Models of Atopic Dermatitis for Preclinical Studies  
por: Martel, Britta C., et al.
Publicado: (2017)

Hemodynamic and Rhythmologic Effects of Push-Dose Landiolol in Critical Care—A Retrospective Cross-Sectional Study
por: Schnaubelt, Sebastian, et al.
Publicado: (2023)

The making of a potent L-lactate transport inhibitor
por: Bosshart, Patrick D., et al.
Publicado: (2021)

Trametinib with and without pazopanib has potent preclinical activity in thyroid cancer
por: BALL, DOUGLAS W., et al.
Publicado: (2015)

Benzothiazinethione is a potent preclinical candidate for the treatment of drug-resistant tuberculosis
por: Gao, Chao, et al.
Publicado: (2016)

Preclinical characterization of tunlametinib, a novel, potent, and selective MEK inhibitor
por: Liu, Yahong, et al.
Publicado: (2023)

Preclinical validation of a potent γ-secretase modulator for Alzheimer’s disease prevention
por: Rynearson, Kevin D., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ktv5v46fevtv92n2aph8mlsvo7